We are live on ! Find out more
BL

BCWM LLC Portfolio holdings

AUM $353M
1-Year Est. Return 20.1%
This Fund
S&P 500
This Quarter Est. Return
+11.48%
1 Year Est. Return
+20.1%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$304M
AUM Growth
+$28.4M
Cap. Flow
+$419K
Cap. Flow %
0.14%
Top 10 Hldgs %
34.57%
Holding
61
New
1
Increased
37
Reduced
21
Closed
1

Top Buys

Rank Stock Value
1
CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
+$2.8M
2
DUK icon
Duke Energy
DUK
+$2.73M
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$781K
4
MSFT icon
Microsoft
MSFT
+$506K
5
VWOB icon
Vanguard Emerging Markets Government Bond ETF
VWOB
+$156K

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$2.55M
2
LMT icon
Lockheed Martin
LMT
+$2.07M
3
HII icon
Huntington Ingalls Industries
HII
+$966K
4
SCHF icon
Schwab International Equity ETF
SCHF
+$735K
5
MDT icon
Medtronic
MDT
+$518K

Sector Composition

Rank Sector Weight
1 Consumer Staples 11.32%
2 Healthcare 9.32%
3 Consumer Discretionary 9.16%
4 Materials 8.83%
5 Industrials 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VCIT icon
51
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
$837K 0.28%
10,800
+216
+2% +$16.6K
LQD icon
52
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.2B
$833K 0.27%
7,899
+232
+3% +$24.3K
VEA icon
53
Vanguard FTSE Developed Markets ETF
VEA
$229B
$809K 0.27%
+19,273
New +$781K
ZROZ icon
54
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.31B
$807K 0.27%
9,244
+925
+11% +$82.8K
SCHZ icon
55
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$739K 0.24%
32,368
+238
+0.7% +$5.42K
PFF icon
56
iShares Preferred and Income Securities ETF
PFF
$13.2B
$523K 0.17%
17,138
+446
+3% +$13.9K
PG icon
57
Procter & Gamble
PG
$335B
$403K 0.13%
2,657
– –
SCHM icon
58
Schwab US Mid-Cap ETF
SCHM
$14.5B
$374K 0.12%
17,097
-267
-2% -$5.85K
SCHA icon
59
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$372K 0.12%
18,364
-226
-1% -$4.63K
PCY icon
60
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
$210K 0.07%
11,247
+396
+4% +$7.16K
XBI icon
61
State Street SPDR S&P Biotech ETF
XBI
$9.93B
– –
-32,177
Closed -$2.55M
1 2
3

Similar funds

FWM
ForthRight Wealth Management Alpharetta, Georgia $353M AUM 12.98% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
OBGC
O'Brien Greene & Co Media, Pennsylvania $353M AUM 30.94% 1-Year Est. Return
EC
Elmind Capital New York $352M AUM
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
PIC
PCJ Investment Counsel Toronto, Ontario, Canada $352M AUM 68.32% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SCA
Strathmore Capital Advisors Charlotte, North Carolina $354M AUM 17.33% 1-Year Est. Return

BCWM LLC's Q4 2022 Portfolio in Review

As of Q4 2022, BCWM LLC held 61 positions worth $304M, up 10% from $275M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 3.3%. BCWM LLC opened 1 new position and exited 1, leaving the 61-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • BCWM LLC's largest Q4 2022 buy was Vanguard FTSE Developed Markets ETF: 19,273 shares worth $809K.
  • BCWM LLC added most to ETF Series Solutions Trust Range Cancer Therapeutics ETF in Q4 2022, an estimated $2.8M increase.
  • BCWM LLC's biggest Q4 2022 reduction was Lockheed Martin, cutting an estimated $2.07M.
  • BCWM LLC fully exited State Street SPDR S&P Biotech ETF in Q4 2022, selling an estimated $2.55M.
  • BCWM LLC's ten largest holdings make up 35% of its $304M portfolio in Q4 2022.
  • BCWM LLC opened 1 new position and closed 1 in Q4 2022.
  • BCWM LLC's portfolio value rose 10% quarter-over-quarter to $304M.

Based on BCWM LLC's 13F filing for Q4 2022, filed 30 Jan 2023.